Corrigendum: Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARSCoV-2 Nucleocapsid protein
Lavanya Visvabharathy(Northwestern University), Igor J. Koralnik(Northwestern University), Jeffrey R. Clark(Northwestern University), Pablo Penaloza‐MacMaster(Northwestern University), Patrick H. Lim(Royal Prince Alfred Hospital), Nicole M. Palacio(Northwestern University), Eric M. Liotta(Northwestern University), Edith L. Graham(Northwestern University), Millenia Jimenez(Northwestern University), George Tachas(Antisense Therapeutics (Australia)), Barbara A. Hanson(Northwestern University), Zachary S. Orban(Northwestern University)
Cited by 3
Related Papers
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”
|Annals of Clinical and Translational Neurology|2021|715
Linking peripheral atherosclerosis to blood–brain barrier disruption: elucidating its role as a manifestation of cerebral small vessel disease in vascular cognitive impairment
|GeroScience|2024|74
Evolution of neurologic symptoms in non‐hospitalized <scp>COVID</scp>‐19 “long haulers”
|Annals of Clinical and Translational Neurology|2022|71